Level 1 — Absolute Beginner
Scientists did a new study about a sickness called HIV. HIV can make people very sick.
The scientists gave baby monkeys three different medicines together, very soon after they got HIV.
One year later, the scientists could not find the virus in the monkeys' bodies anymore.
This is exciting news. It might help doctors protect human babies from HIV one day.
- scientist
- a person who studies the world through careful research
- study
- careful research done to learn about something
- sickness
- an illness or disease
- medicine
- something used to treat or prevent illness
- infant
- a very young baby
- detect
- to notice or discover the presence of something
- protect
- to keep someone or something safe from harm
- virus
- a tiny germ that can cause disease
Level 2 — Elementary
Researchers have found a promising new way to treat HIV in newborns, using a combination of three different therapies given very soon after infection.
In the study, scientists gave eight infant macaque monkeys the triple therapy within three days after they were infected with a virus similar to HIV.
About a year after the treatment ended, doctors could not detect the virus anywhere in the monkeys' bodies, even after looking very closely.
The research team, led by Oregon Health and Science University, published the results in the journal Nature Microbiology, and they hope the approach could someday help newborn babies exposed to HIV at birth.
- promising
- showing signs of future success or good results
- therapy
- treatment intended to relieve or cure a health problem
- combination
- a mixture of different things used together
- infected
- having a disease caused by a virus, bacteria, or other germ
- macaque
- a type of monkey often used in medical research
- closely
- carefully and in great detail
- research team
- a group of scientists working together on a study
- approach
- a way of dealing with or handling something
Level 3 — Intermediate
A team of researchers has demonstrated a striking new strategy for potentially clearing HIV soon after infection, using a one time combination of three distinct therapies delivered to newborn primates within 72 hours of exposure to the virus.
The regimen combined broadly neutralizing antibodies, standard antiretroviral therapy, and an experimental monoclonal antibody called leronlimab, which works by blocking the virus from entering immune cells through a surface protein known as CCR5.
Among the eight infant macaques treated with the full combination, researchers found no detectable virus anywhere they looked roughly a year after the therapy was discontinued, a result the study's authors, led by Oregon Health and Science University, described as remarkable.
The combination proved far more effective than any single therapy administered alone, though the researchers caution that the finding does not establish a cure in human newborns, since no infant has yet been treated this way, and they are now proposing clinical trials to test the approach directly.
- strategy
- a planned approach designed to achieve a particular goal
- primate
- a member of the group of mammals that includes humans, apes, and monkeys
- regimen
- a planned course of treatment or activity
- antibody
- a protein made by the immune system to fight infection
- antiretroviral
- a type of drug that slows or stops the reproduction of viruses like HIV
- monoclonal
- describing a laboratory made antibody derived from a single cell type
- administered
- given or applied, typically referring to medicine
- clinical trial
- a research study testing a treatment's safety and effectiveness in people
Level 4 — Advanced
A research team has documented a striking proof of concept for arresting HIV shortly after infection, administering a brief, one time combination of three distinct therapeutic modalities to newborn primates within 72 hours of viral exposure, a window researchers regard as critical for preventing the virus from establishing durable reservoirs in the body.
The regimen paired broadly neutralizing antibodies and conventional antiretroviral therapy with leronlimab, an experimental monoclonal antibody that impedes viral entry into immune cells by blocking CCR5, the coreceptor the virus exploits to infiltrate its target cells.
Across eight infant macaques that received the full triple combination, investigators, led by a team at Oregon Health and Science University and publishing in Nature Microbiology, reported no detectable virus by any assay employed roughly a year after treatment was discontinued, a result the authors characterized as remarkable relative to outcomes from any single therapeutic agent administered in isolation.
The researchers were careful to temper enthusiasm, noting that the finding does not establish efficacy or safety in human newborns, since no infant has received this regimen, and they are now advocating for the rapid initiation of clinical trials, first among newly exposed infants and subsequently among newly infected adults, to determine whether the approach translates beyond the primate model.
- proof of concept
- a demonstration showing that an idea or method is feasible
- therapeutic modality
- a distinct method or type of treatment
- reservoir
- in medicine, a site in the body where a pathogen persists undetected
- coreceptor
- a secondary protein that assists a primary receptor in a biological process
- infiltrate
- to enter or penetrate something gradually or stealthily
- assay
- a laboratory test used to measure or detect a substance
- efficacy
- the ability of a treatment to produce the intended result
- temper
- to moderate or restrain the intensity of something
Talk about this article with KatePractice this story's vocabulary in a real spoken conversation with your AI tutor